Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Adaptimmune Therapeutics PLC insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Adaptimmune Therapeutics PLC, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wood Gavin | Chief Financial Officer | 0 | Sep 3, 2025 | 0 |
| Bertrand William C JR | Chief Operating Officer | 986,352 | Aug 29, 2025 | 0 |
| Behbahani Ali | Director | 0Indirect | Aug 19, 2025 | 0 |
| EcoR1 Capital, LLC | 10% Owner | 100,371,882Indirect | Jul 30, 2025 | 0 |
| Rawcliffe Adrian | Chief Executive Officer | 44,327 | Feb 20, 2025 | 0 |
| Lunger John | Chief Patient Supply Officer | 7,510 | Feb 20, 2025 | 0 |
| Norry Elliot | Chief Medical Officer | 7,510 | Feb 20, 2025 | 0 |
| Piccina Cintia | Chief Commercial Officer | 18,421 | Feb 20, 2025 | 0 |
| Brewer Joanna Elizabeth | Chief Scientific Officer | – | Feb 20, 2025 | 0 |
| Mott David M | Director | – | Jul 1, 2024 | 0 |
| Hege Kristen | Director | – | Jul 1, 2024 | 0 |
| Allen Andrew R | Director | – | Jul 1, 2024 | 0 |
| Alleva Lawrence M | Director | – | Jul 1, 2024 | 0 |
| Menzel Garry E | Director | 75,056 | Jul 1, 2024 | 0 |
| Furey John | Director | – | Jul 1, 2024 | 0 |
| Hegde Priti | Director | – | Jul 1, 2024 | 0 |
| Tayton-Martin Helen Katrina | Chief Business & Strgy Officer | – | Jan 17, 2024 | 0 |
| Sigal Charles Elliott | Director | – | Jul 3, 2023 | 0 |
| Duncan Barbara Gayle | Director | – | Jul 1, 2022 | 0 |
| Noble James | Director | – | Jul 1, 2022 | 0 |
| Zaks Tal Zvi | Director | – | Jul 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2022 (view filing) | Jan 11-12 | 2 days | Lunger JohnChief Patient Supply Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −4.85K | $3.56 | −$17.2K | −73.5%1.75K after | 2 lots |
| Jan 13, 2022 (view filing) | Jan 11-12 | 2 days | Norry ElliotChief Medical Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −4.62K | $3.56 | −$16.4K | −77.0%1.38K after | 2 lots |
| Jan 13, 2022 (view filing) | Jan 11-12 | 2 days | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −17.4K | $3.56 | −$61.9K | −83.8%3.36K after | 2 lots |
| Jan 5, 2022 (view filing) | Jan 4 | 1 day | Bertrand William C JRChief Operating Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −3.49K | $4.06 | −$14.2K | −37.3%5.87K after | |
| Jan 5, 2022 (view filing) | Jan 4 | 1 day | Lunger JohnChief Patient Supply Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −1.07K | $4.06 | −$4.34K | −37.9%1.75K after | |
| Jan 5, 2022 (view filing) | Jan 4 | 1 day | Norry ElliotChief Medical Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −849 | $4.06 | −$3.45K | −38.0%1.39K after | |
| Jan 5, 2022 (view filing) | Jan 4 | 1 day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −5.53K | $4.06 | −$22.5K | −47.3%6.17K after | |
| Sep 1, 2021 (view filing) | Sep 1 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −2.78K | $5.20 | −$14.5K | −47.5%3.07K after | |
| Aug 2, 2021 (view filing) | Aug 2 | Same day | Lunger JohnChief Patient Supply Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −2.94K | $3.58 | −$10.5K | −37.6%4.87K after | |
| Jul 2, 2021 (view filing) | Jul 2 | Same day | Bertrand William C JRChief Operating Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −4.38K | $4.26 | −$18.6K | −37.4%7.33K after | |
| Jul 2, 2021 (view filing) | Jul 2 | Same day | Lunger JohnChief Patient Supply Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −1.91K | $4.26 | −$8.12K | −37.6%3.17K after |